Practitioners in the scientific research area on the development and use of generics and biosimilar medicines who would like to author papers on related topics, and whose manuscripts comply with the editorial policy of GaBI Journal, are welcome to submit their manuscripts for assessment, peer review and publication in GaBI Journal.
Only original papers written in English are considered and all articles must be submitted through the Editorial Office. All authors must sign a Conflict of Interest Disclosure statement and copyright transfer form at time of submission.
Please review our Instructions for Authors prior to submitting a manuscript.
Should you experience any problems with your submission, please contact:
Pro Pharma Communications International
GaBI Journal Editorial office Postbus 10001
The authors are encouraged to propose potential reviewers. Click here for further information.
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.